We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone.
- Authors
Macedo, Thais Rodrigues; de Queiroz, Genilson Fernandes; Casagrande, Thaís Andrade Costa; Alexandre, Pâmela Almeida; Brandão, Paulo Eduardo; Fukumasu, Heidge; Melo, Samanta Rios; Dagli, Maria Lucia Zaidan; Pinto, Ana Carolina B. C. Fonseca; Matera, Julia Maria
- Abstract
Mast cell tumors (MCTs) are common neoplasms in dogs, and treatments for these diseases include surgery, polychemotherapy and targeted therapy with tyrosine kinase inhibitors. This study aimed to evaluate the response and the adverse events of treatment with imatinib mesylate (IM) compared to conventional therapy using vinblastine and prednisolone (VP) in canine cutaneous MCTs. Twenty-four dogs were included in the study; 13 animals were treated with IM and 11 with VP. Tumor tissue samples were submitted for histological diagnosis, grading and KIT immunostaining. The response to treatment was assessed by tomographic measurements according to VCOG criteria. Adverse events were classified according to VCOG-CTCAE criteria. The IM and VP groups had dogs with similar breeds, gender, ages, MCT localization, WHO stages and lymph node metastasis profiles. Most MCTs were grade 2/low and had KIT- patterns 2 and 3. The objective response rate (ORR) was significantly higher (30.79%) in the IM group then in VP group (9.09%). Adverse events (AE) in IM group were all grade 1, significantly different from VP. In conclusion, IM presented better ORR and less severe adverse events when compared to VP, representing a suitable option for the treatment of low-grade canine MCTs.
- Subjects
MAST cell tumors; NILOTINIB; VINBLASTINE; IMATINIB; THERAPEUTICS; PROTEIN-tyrosine kinase inhibitors
- Publication
Cells (2073-4409), 2022, Vol 11, Issue 3, p571
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells11030571